MillerKnoll (MLKN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
10 Jan, 2026Executive summary
Q2 FY2025 net sales rose 2.2% year-over-year to $970.4 million, with organic growth of 2.4%; orders declined 2.3% as reported and 1.9% organically.
Adjusted EPS for Q2 FY2025 was $0.55, down from $0.59 last year; reported EPS was $0.49, up from $0.45.
Americas Contract segment drove growth with 5.9% higher sales and 4.4% higher orders; Global Retail sales declined 5.3% due to timing of promotions.
Returned $93.1 million to shareholders via dividends and share repurchases in the first half of FY2025.
Cash flow from operations in Q2 was $55.3 million; liquidity at quarter-end was $470.4 million.
Financial highlights
Q2 consolidated net sales: $970.4 million, up 2.2% year-over-year (2.4% organic).
Q2 consolidated orders: $921.9 million, down 2.3% as reported and 1.9% organically.
Gross margin: 38.8%, slightly down from last year due to product and channel mix.
Adjusted operating margin for Q2 FY2025 was 7.1%, down from 7.9% last year.
Net debt-to-EBITDA ratio stood at 2.94x at quarter-end.
Outlook and guidance
Q3 FY2025 net sales expected between $903 million and $943 million; adjusted EPS guidance of $0.41–$0.47.
Full-year FY2025 adjusted EPS guidance narrowed to $2.11–$2.17, reflecting slower macro improvements and lower orders in H1.
Guidance incorporates typical Q3 seasonal softness and the shift in the holiday promotional period, with $12 million in Global Retail net sales moving from Q2 to Q3.
Full-year sales and EPS still expected to grow over FY2024.
Full-year capital expenditures expected between $100 million and $125 million.
Latest events from MillerKnoll
- Q3 FY2026 delivered sales growth, margin gains, and strong order momentum despite global risks.MLKN
Q3 202625 Mar 2026 - Margins and EPS rose in Q4 despite lower sales, with a strong outlook for FY2025.MLKN
Q4 20243 Feb 2026 - Order and backlog growth offset lower sales; FY2025 adjusted EPS guidance reaffirmed.MLKN
Q1 202520 Jan 2026 - Orders rose 5.5% and gross margin hit 39.0%, offsetting a 1.6% sales decline.MLKN
Q2 20265 Jan 2026 - $130M impairment drove Q3 loss, but retail orders and guidance remain strong.MLKN
Q3 202526 Dec 2025 - Profitability improved, global reach expanded, and sustainability advanced; all proposals recommended for approval.MLKN
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, executive pay, auditor, and new incentive plan amid growth focus.MLKN
Proxy Filing1 Dec 2025 - Key votes: director elections, executive pay, auditor ratification, and incentive plan approval.MLKN
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay approval, and auditor ratification.MLKN
Proxy Filing1 Dec 2025